Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial.

For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy.

Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.

Mantle Cell Lymphoma Study CRAD001N2201

The purpose of this clinical research is to study how safe and effective a Novartis investigational drug is when treating people with mantle cell lymphoma, whose condition has progressed despite existing treatment(s). An “investigative drug” is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).